More Slippage on test release dates

Follow the timeline.. Not good..

First announcement:
Melbourne, Australia, 16 July 2018:
GTG...announced today that both its new breast cancer and colorectal cancer risk assessment tests are on track for release in October 2018. In addition... the following tests available over the next 12 months:
● Prostate Cancer
● Melanoma
● Type 2 Diabetes
● Cardiovascular Disease

2nd Update:
4c HIGHLIGHTS - 30 September 2018
● Enhanced breast cancer test which increases the applicability of our current BREVAGenplus® test to 95% of women is on schedule for launch in early 2019.
● First in class colon cancer risk assessment test on schedule for launch in early 2019.

3rd Update:
4c Highlights - 30 January 2019
● Enhanced breast cancer test... remains on schedule for launch in FY19.
● First in class colon cancer risk assessment test on schedule for launch in FY19.

same ann:..."The launch of the website and media campaign will coincide with the introduction of the enhanced breast cancer test and the colon cancer tests in Q3 and Q4 FY19."

On track release Oct'18 now to Q1-19 & now has gone to Q3-Q4 FY19?
From the above info GTG needs to clarify on what "on track" & "on schedule" actually mean...
So now FY19 meaning? Full Year 2019 or Fiscal Year 2019.???

Meanwhile Market confidence wanes.
No wonder the SP is sliding, thanks GTG...

Rp.
.